Home | Site Map
 
 
[.:Partners:.]

[.:Contenuti:.]
TUMOR STUDY

Smoking, HPV might combine to cause cervical cancer: Study EARTHtimes.org
The interplay between heavy smoking and human papillomavirus (HPV) could boost the risk of developing precancerous cervical lesions and consequently cervical cancer, according to a new study by researchers at the Karolinska Institutet in Stockholm, Sweden.
Study Reinforces Potential Utility of ONCONASER in Non-Small-Cell Lung Cancer RedNova
Alfacell Corporation (NASDAQ: ACEL) today announced the presentation of preclinical findings based on histological evidence and provide further support for the potential anti-tumor activity of ONCONASE® (ranpirnase) in non-small-cell lung cancer (NSCLC).
Stanford gets $20M to study cancer The Daily Review
The Stanford University School of Medicine has received a $20 million gift to set up a research institute devoted to the study of cancer stem cells, the university announced Tuesday.
Early Cancer Vaccine Results Are Promising CBS News
An experimental colorectal cancer vaccine designed to enlist the immune system in killing tumor cells is showing promise in an early clinical trial, research shows.
Early Cancer Vaccine Results Promising CBS News
An experimental colorectal cancer vaccine designed to enlist the immune system in killing tumor cells is showing promise in an early clinical trial.
Helsinn discontinues tumor trial program Pharmaceutical Business Review
Exelixis has said that its licensee Helsinn Healthcare has discontinued enrollment of new patients in the becatecarin phase III clinical trial program in biliary tract tumors when it was found that chemotherapy was more effective.
Intravenous Chemoradiation Effective For Inoperable Head, Neck Cancer; Easier For Patients, Doctors Science Daily
Chemoradiation (radiation and chemotherapy given at the same time) given through a needle or tube inserted into a vein (intravenous) is as effective as treatment given directly to the tumor through a tube inserted into an artery (intra-arterial) for patients with inoperable head and neck cancer, according to a randomized study presented at the plenary session November 6, 2006, at the American
Seattle Genetics starts clinical trial for SGN-35 drug bizjournals.com via Yahoo! Finance
Seattle Genetics Inc. will study the effect of drug SGN-35 on patients with Hodgkin's disease and other blood- and lymph-related malignancies, the company announced Friday.
Novel Regulatory Mechanism Identified for Key Tumor Suppressor p53 Newswise
Collaborating scientists from The Wistar Institute in Philadelphia and The Vienna Biocenter in Austria have identified a novel mechanism involved in normal repression of the p53 protein, perhaps the single most important molecule for the control of cancer in humans. The new molecular pathway described in the study suggests intriguing approaches to diagnosing or intervening in the progression of
Enbrel Provides Sustained Clinical Improvements For Ankylosing Spondylitis For Up To 3 Years Medical News Today
On 13-Nov-2006 Amgen (NASDAQ: AMGN) announced that data from an ongoing open-label, multinational, phase 4 extension study showed that patients with ankylosing spondylitis (AS) who received treatment with Enbrel (etanercept) experienced sustained improvement in signs and symptoms, spinal mobility and physical function over 148 to 160 weeks of therapy. [click link for full article]

Rat & Mouse Gazette: Medical Corner: Tumor Study
Tumor Study by Kaleigh Hessel. rats I currently have that are ages two or more, two have had at least one mammary tumor and one has a pituitary tumor.
Bone Marrow Transplant for solid tumor study program
Program from the University of Texas MD Anderson's Center. Articles, appointments and links.
Brain tumor study reveals why treatment efforts fail in genetic
Drugs used to treat the tumors common in people with a disorder called neurofibromatosis 1 rarely work, and scientists now know why.
CancerWise - CancerWise - September 2004 - Brain Tumor Study
CancerWise is a monthly electronic publication that contains information about the latest advancements in cancer treatment and research,
National Wilms Tumor Study Group - Wikipedia, the free encyclopedia
National Wilms Tumor Study Group - home page. Retrieved from "http://en.wikipedia.org/wiki/National_Wilms_Tumor_Study_Group"

Bone Marrow Transplant for solid tumor study program
Program from the University of Texas MD Anderson's Center. Articles, appointmen and links.
Brain tumor study reveals why treatment effor fail in genetic
Drugs used to treat the tumors common in people with a disorder called nefibromatosis 1 rarely work, and scientis now w why.
CancerWise CancerWise September 2004 Brain Tumor Study
CancerWise is a monthly electronic publication that contains information about the latest advancemen in cancer treatment and research,
National Wilms Tumor Study Group Wikipedia, the free encyclopedia
National Wilms Tumor Study Group home page. Retrieved from "http://en.wikipedia.org/wiki/National_Wilms_Tumor_Study_Group"
Island Fox
This is part of a larger study that will also involve collection of the same tissues on two of the other Channel Islands (San Clemente and Santa Catalina)
Glioblastoma Brain Tumor Study
Glioblastoma Brain Tumor Study. Researchers at the University of Kentucky Chandler Medical Center are. conducting a clinical research study to evaluate an
Pancreatic Tumor Study Group: Who are the Pancreatic Tumor Study
To view additional information about our Pancreatic Tumor Study Group specialis, listed below, c on his/her name. (New bios are in progress.)
Rhabdoid tumor of the kidney in the national wilms' tumor study
Purpose The objective of this study is to determine prognostic factors in rhabdoid tumor of the kidney(RTK), including both demographic and treatment
Cerca con Google


 
 
All rights reserved. info sol sito email Tutti i diritti sono riservati.